“…Additionally, an immunogenically enhancing vaccine candidate that possesses a stronger ability to induce neutralizing antibody has been developed by mutating the glycosylation sites in GP5 [ 20 , 21 , 22 ]. Moreover, four regions in the PRRSV genome, including the interval between ORF1b and ORF2, the spacer between ORF4 and ORF5a, the position post-ORF7, and the highly variable region within nsp2, have been applied for carrying exogenous genes using a reverse genetics system, which provides the potential for the development of polyvalent vaccines based on PRRSV [ 23 , 24 , 25 , 26 ].…”